CLs上限
药方
小桶
医学
计算生物学
基因本体论
传统医学
生物信息学
药理学
基因
生物
遗传学
基因表达
验光服务
作者
Ming‐Liang Hu,Tian-Xing Yi,Qirui Liu,Xinyu Zhang,Aiping Chen,Yuying Wang,Yi Lu
标识
DOI:10.4103/2311-8571.382287
摘要
Abstract Objective: The objective of this study was to explore the medication rules and academic ideas of Professor Wang Yu-Ying in the treatment of climacteric syndrome (CLS) and to predict new prescriptions. Materials and Methods: The characteristics of frequency, clustering, four properties, and five flavors were analyzed, and new prescriptions were predicted through an artificial intelligence (AI)-based method. The potential pathways of new prescriptions were explored through network pharmacology-based analysis. Results The top 16 medicinals used by Professor Wang Yu-Ying in the treatment of CLS included Danggui, Longgu, Muli, Fuling, Chuanxiong, Gancao, Xiangfu, and Tusizi. The AI method was applied to predict the basic prescription for treating CLS Danggui 15 g, Duanlonggu 30 g, Duanmuli 30 g, Fuling 28 g, Chuanxiong 10 g, Gancao 6 g, Xiangfu 12 g, Tusizi 14 g, etc., Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses showed that the pathogenesis of CLS might be related to the estrogen pathway, involving typical steroid responses. Conclusions This study summarized Professor Wang’s medication experience in the treatment of CLS based on the data mining of clinical diagnoses and treatment cases. The AI method was used to predict the new prescription of CLS treatment, which was found to be reasonable by network pharmacology studies on its multi-target and multi-pathway mechanisms.
科研通智能强力驱动
Strongly Powered by AbleSci AI